Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation. [PDF]
PeerJFan J, Song Y.
europepmc +1 more source
cGAS/STING-mediated upregulation of NKG2D ligands in LSCs contributes to enhanced sensitivity to NK cells. [PDF]
Front OncolOuyang Y, Qin Y, Zhang Q, Zhu P, Zhu H.
europepmc +1 more source
HPF1 regulates the formation of FUS-dependent compartments by PARP1 and PARP2 activation on damaged DNA. [PDF]
Nucleic Acids ResSingatulina AS +5 more
europepmc +1 more source
Core targets of bisphenol A in cervical cancer revealed by network toxicology and molecular docking. [PDF]
Medicine (Baltimore)Li Y +6 more
europepmc +1 more source
Epacadostat and Olaparib Synergistically Inhibit the Growth of BRCA-Proficient Triple-Negative Breast Cancer by Suppressing the Expression of BRCA1 and RAD51. [PDF]
MoleculesHuang L +5 more
europepmc +1 more source
Bioengineered exosome-mRNA hybrids: a breakthrough in targeted miRNA delivery for diabetic kidney fibrosis therapy. [PDF]
Front Bioeng BiotechnolKe J, Cao L, Zhang S, Xing J.
europepmc +1 more source
Understanding single stranded DNA gaps: from formation to fate. [PDF]
Biochem JGarg S, Moldovan GL.
europepmc +1 more source
Interplay Between Poly(ADP-ribosyl)ation and Specific Inner Cellular Events That Suggest Combination Strategies for Overcoming PARP Inhibitor Resistance. [PDF]
PharmaceuticsXu L +9 more
europepmc +1 more source
PARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges. [PDF]
CellsMatsuoka T +4 more
europepmc +1 more source
Synaptic potentiation requires PARP1 activation: prevailing concepts are revisited. [PDF]
Mol PsychiatryCohen-Armon M, Segal M.
europepmc +1 more source